IARC Monographs Volume 100B
Epstein-Barr Virus

Supplementary Web Tables, Section 2, Cancer in Humans

  These web tables formed part of the original submission and have been peer reviewed. They
  are posted as supplied by the Working Group. Readers are requested to report any errors to:
  edit-vol100B@iarc.fr.
Table 2.1   Case–control studies of Epstein-Barr virus infection markers and Burkitt lymphoma (BL)
Table 2.2   Cohort studies of Epstein-Barr virus infection markers and Hodgkin lymphoma (HL)
Table 2.3   Case–control studies of Epstein-Barr virus infection markers and Hodgkin lymphoma (HL)
Table 2.4   Case–control studies of Epstein-Barr virus infection markers and non-Hodgkin lymphoma
                    (NHL)
Table 2.5   Nested case–control study of Epstein-Barr virus infection markers and Kaposi sarcoma
                    and non-Hodgkin lymphoma
Table 2.6   Cohort studies of Epstein-Barr virus infection markers and nasopharyngeal carcinoma
                    (NPC)
Table 2.7   Case–control studies of Epstein-Barr virus infection markers and nasopharyngeal
                    carcinoma (NPC)
Table 2.8   Case–control studies of Epstein-Barr virus infection and lymphoepithelial-like carcinoma of
                    major salivary glands
Table 2.9   Case–control studies of Epstein-Barr virus infection markers and gastric carcinoma
Table 2.10 Nested case–control studies of Epstein-Barr virus infection markers and gastric carcinoma
Table 2.11 Case–control studies of Epstein-Barr virus infection and oral squamous cell carcinoma
Table 2.12 Case–control studies of Epstein-Barr virus infection markers and breast cancer
Table 2.13 Case–control studies of Epstein-Barr virus infection and testicular cancer